Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-07-01
|
Series: | Cancer Cell International |
id |
doaj-a1c67716884c4ee98e7ebba639d6e9be |
---|---|
record_format |
Article |
spelling |
doaj-a1c67716884c4ee98e7ebba639d6e9be2020-11-25T02:11:46ZengBMCCancer Cell International1475-28672004-07-014Suppl 1S4910.1186/1475-2867-4-S1-S49Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccinesNadler LMFiore FMaecker Bvon Bergwelt-Baildon MSSchultze JL |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nadler LM Fiore F Maecker B von Bergwelt-Baildon MS Schultze JL |
spellingShingle |
Nadler LM Fiore F Maecker B von Bergwelt-Baildon MS Schultze JL Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines Cancer Cell International |
author_facet |
Nadler LM Fiore F Maecker B von Bergwelt-Baildon MS Schultze JL |
author_sort |
Nadler LM |
title |
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines |
title_short |
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines |
title_full |
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines |
title_fullStr |
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines |
title_full_unstemmed |
Biological characterization of CD40-activated B cells as a prerequisite for their use as cellular adjuvant in cancer vaccines |
title_sort |
biological characterization of cd40-activated b cells as a prerequisite for their use as cellular adjuvant in cancer vaccines |
publisher |
BMC |
series |
Cancer Cell International |
issn |
1475-2867 |
publishDate |
2004-07-01 |
work_keys_str_mv |
AT nadlerlm biologicalcharacterizationofcd40activatedbcellsasaprerequisitefortheiruseascellularadjuvantincancervaccines AT fioref biologicalcharacterizationofcd40activatedbcellsasaprerequisitefortheiruseascellularadjuvantincancervaccines AT maeckerb biologicalcharacterizationofcd40activatedbcellsasaprerequisitefortheiruseascellularadjuvantincancervaccines AT vonbergweltbaildonms biologicalcharacterizationofcd40activatedbcellsasaprerequisitefortheiruseascellularadjuvantincancervaccines AT schultzejl biologicalcharacterizationofcd40activatedbcellsasaprerequisitefortheiruseascellularadjuvantincancervaccines |
_version_ |
1724912764405678080 |